|
Clinical Trials
Phase I – III clinical trials may include the need to analyse patient tissue biopsies pre and post treatment, as a gold standard assessment of treatment. Analysis includes assessment of routine haematoxylin and eosin stained sections for morphological parameters of drug efficacy, plus analysis of immunohistochemical stained sections for biomarker assessment.
We offer an expert, fast and efficient service including:
- Analysis of baseline patient tissue samples, pre and post treatment samples, prior to genetic studies or immunohistochemical staining
- Assessment of immunohistochemical stained sections via semi-quantitative scoring methods, quantitative scoring of biomarkers according to standardised/clinical protocols, microvessel density scoring etc.
- We have experience with many commercial image analysis systems and software programmes.
- Preparation of full report spreadsheets tailored to customer needs and deadlines and meeting regulatory requirements
Our fully qualified, board certified and currently practicing human diagnostic pathologist with over 15 years experience in human diagnostic pathology can relate your study findings to the clinical situation, and is capable of interpreting all human diagnostic tissue pathology samples across many organ systems and disease processes.
|
